NASDAQ:HZNP

Horizon Therapeutics Public News Headlines

$91.30
-1.26 (-1.36 %)
(As of 06/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$90.91
$92.98
50-Day Range
$86.24
$95.75
52-Week Range
$47.28
$97.36
Volume817,832 shs
Average Volume1.76 million shs
Market Capitalization$20.52 billion
P/E Ratio78.71
Dividend YieldN/A
Beta1.11

Horizon Therapeutics Public (NASDAQ HZNP) News Headlines Today

SourceHeadline
Maxim Group Reiterates "Reduce" Rating for Horizon Therapeutics Public (NASDAQ:HZNP)Maxim Group Reiterates "Reduce" Rating for Horizon Therapeutics Public (NASDAQ:HZNP)
marketbeat.com - May 27 at 8:41 AM
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Shares Could Be 42% Below Their Intrinsic Value EstimateHorizon Therapeutics Public Limited Company (NASDAQ:HZNP) Shares Could Be 42% Below Their Intrinsic Value Estimate
finance.yahoo.com - June 8 at 11:48 AM
Zacks: Analysts Anticipate Horizon Therapeutics Public Limited (NASDAQ:HZNP) to Post $0.93 Earnings Per ShareZacks: Analysts Anticipate Horizon Therapeutics Public Limited (NASDAQ:HZNP) to Post $0.93 Earnings Per Share
americanbankingnews.com - June 6 at 1:18 AM
Horizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of RheumatologyHorizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of Rheumatology
finance.yahoo.com - June 2 at 8:05 AM
Horizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA MonotherapyHorizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA Monotherapy
finance.yahoo.com - May 27 at 12:41 PM
Horizon Therapeutics Public (NASDAQ:HZNP) Given Reduce Rating at Maxim GroupHorizon Therapeutics Public (NASDAQ:HZNP) Given Reduce Rating at Maxim Group
americanbankingnews.com - May 27 at 10:10 AM
Is There An Opportunity With Horizon Therapeutics Public Limited Companys (NASDAQ:HZNP) 40% Undervaluation?Is There An Opportunity With Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) 40% Undervaluation?
nasdaq.com - May 24 at 2:15 PM
Horizon Therapeutics Public (NASDAQ:HZNP) Sets New 12-Month High at $97.34Horizon Therapeutics Public (NASDAQ:HZNP) Sets New 12-Month High at $97.34
americanbankingnews.com - May 24 at 1:12 PM
Horizon Therapeutics plc Highlights Expanding R&D Efforts with Data Presentations at the EULAR European Congress of RheumatologyHorizon Therapeutics plc Highlights Expanding R&D Efforts with Data Presentations at the EULAR European Congress of Rheumatology
finance.yahoo.com - May 21 at 10:42 AM
Horizon Therapeutics plc Named One of the 2021 Best Workplaces in Chicago™ by Great Place to Work®Horizon Therapeutics plc Named One of the 2021 Best Workplaces in Chicago™ by Great Place to Work®
finance.yahoo.com - May 20 at 12:32 PM
Horizon Therapeutics plc to Present at the Bank of America Securities 2021 Health Care ConferenceHorizon Therapeutics plc to Present at the Bank of America Securities 2021 Health Care Conference
finance.yahoo.com - May 6 at 5:16 PM
New Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & NeuroinflammationNew Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & Neuroinflammation
finance.yahoo.com - May 6 at 12:15 PM
Horizon Therapeutics Public Limited Company 2021 Q1 - Results - Earnings Call PresentationHorizon Therapeutics Public Limited Company 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 5 at 3:08 PM
Horizon Therapeutics (HZNP) Misses Q1 Earnings EstimatesHorizon Therapeutics (HZNP) Misses Q1 Earnings Estimates
msn.com - May 5 at 11:06 AM
Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.
finance.yahoo.com - May 5 at 11:06 AM
Was The Smart Money Right About Horizon Therapeutics (HZNP)?Was The Smart Money Right About Horizon Therapeutics (HZNP)?
finance.yahoo.com - May 4 at 2:29 PM
We Think Shareholders Will Probably Be Generous With Horizon Therapeutics Public Limited Companys (NASDAQ:HZNP) CEO CompensationWe Think Shareholders Will Probably Be Generous With Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) CEO Compensation
nasdaq.com - April 24 at 2:44 PM
We Take A Look At Why Horizon Therapeutics Public Limited Companys (NASDAQ:HZNP) CEO Has Earned Their Pay PacketWe Take A Look At Why Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) CEO Has Earned Their Pay Packet
finance.yahoo.com - April 24 at 2:44 PM
Does Horizon Therapeutics (NASDAQ:HZNP) Have A Healthy Balance Sheet?Does Horizon Therapeutics (NASDAQ:HZNP) Have A Healthy Balance Sheet?
nasdaq.com - April 21 at 1:49 PM
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for GoutHemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
finance.yahoo.com - April 21 at 8:49 AM
New Integrated Data and Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published in The Lancet Diabetes & EndocrinologyNew Integrated Data and Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published in The Lancet Diabetes & Endocrinology
finance.yahoo.com - April 16 at 9:04 AM
New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - April 16 at 9:04 AM
Biotech Stock On Earnings Win Streak Sets Up Bullish ChartBiotech Stock On Earnings Win Streak Sets Up Bullish Chart
finance.yahoo.com - April 12 at 7:16 PM
Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®
finance.yahoo.com - April 12 at 9:14 AM
Horizon Therapeutics plc to Release First-Quarter 2021 Financial Results and Host Webcast on May 5, 2021Horizon Therapeutics plc to Release First-Quarter 2021 Financial Results and Host Webcast on May 5, 2021
finance.yahoo.com - April 8 at 9:07 AM
RECIPE Randomized Controlled Trial Data Published in Arthritis & Rheumatology Show Higher Response Rates Using KRYSTEXXA® (pegloticase injection) with the Immunomodulator Mycophenolate MofetilRECIPE Randomized Controlled Trial Data Published in Arthritis & Rheumatology Show Higher Response Rates Using KRYSTEXXA® (pegloticase injection) with the Immunomodulator Mycophenolate Mofetil
finance.yahoo.com - April 7 at 8:12 AM
New UPLIZNA® (inebilizumab-cdon) Data in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the American Academy of Neurology’s 73rd Annual MeetingNew UPLIZNA® (inebilizumab-cdon) Data in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the American Academy of Neurology’s 73rd Annual Meeting
finance.yahoo.com - April 5 at 1:23 PM
Horizon Therapeutics plc to Resupply Market With TEPEZZA® (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Beginning in AprilHorizon Therapeutics plc to Resupply Market With TEPEZZA® (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Beginning in April
finance.yahoo.com - March 30 at 8:57 AM
Is Horizon Therapeutics (HZNP) A Good Stock to Short?Is Horizon Therapeutics (HZNP) A Good Stock to Short?
finance.yahoo.com - March 25 at 1:57 PM
First Patient Enrolls in FORWARD Trial to Evaluate Monthly Dosing of KRYSTEXXA® (pegloticase injection) and Methotrexate to Treat Uncontrolled GoutFirst Patient Enrolls in FORWARD Trial to Evaluate Monthly Dosing of KRYSTEXXA® (pegloticase injection) and Methotrexate to Treat Uncontrolled Gout
finance.yahoo.com - March 25 at 8:54 AM
Horizon Therapeutics plc Launches The Horizon Prize with Massachusetts Institute of Technology (MIT) Solve to Advance Solutions for the Rare Disease CommunityHorizon Therapeutics plc Launches The Horizon Prize with Massachusetts Institute of Technology (MIT) Solve to Advance Solutions for the Rare Disease Community
finance.yahoo.com - March 24 at 9:31 AM
UPLIZNA® (inebilizumab-cdon) Approved by Japanese Ministry of Health, Labour and Welfare for the Prevention of Relapses of Neuromyelitis Optica Spectrum Disorder (NMOSD)UPLIZNA® (inebilizumab-cdon) Approved by Japanese Ministry of Health, Labour and Welfare for the Prevention of Relapses of Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - March 24 at 9:31 AM
Is HZNP Stock A Buy or Sell?Is HZNP Stock A Buy or Sell?
finance.yahoo.com - March 23 at 1:29 PM
Horizon Therapeutics Public Limited Companys (NASDAQ:HZNP) Stock Is Going Strong: Have Financials A Role To Play?Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) Stock Is Going Strong: Have Financials A Role To Play?
finance.yahoo.com - March 22 at 12:17 PM
Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.
finance.yahoo.com - March 15 at 10:02 AM
Horizon Therapeutics plc Named Number One Best Workplace in BiopharmaHorizon Therapeutics plc Named Number One Best Workplace in Biopharma
finance.yahoo.com - March 12 at 5:40 PM
Horizon Therapeutics plc Named as One of the Best Workplaces in IrelandHorizon Therapeutics plc Named as One of the Best Workplaces in Ireland
finance.yahoo.com - March 11 at 4:59 AM
Biotech stocks are a buy — especially these 18 picksBiotech stocks are a buy — especially these 18 picks
finance.yahoo.com - March 9 at 1:37 PM
Horizon Therapeutics Pivots Towards Explosive Earnings GrowthHorizon Therapeutics Pivots Towards Explosive Earnings Growth
finance.yahoo.com - March 8 at 2:21 PM
Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care ConferenceHorizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference
finance.yahoo.com - February 26 at 5:45 PM
Why Horizon Therapeutics Stock Jumped TodayWhy Horizon Therapeutics Stock Jumped Today
msn.com - February 25 at 12:48 AM
Why Horizon Therapeuticss Stock is Trading Higher TodayWhy Horizon Therapeutics's Stock is Trading Higher Today
msn.com - February 24 at 2:47 PM
Horizon Posts Triple-Digit Sales Growth After Adding Tepezza To LineupHorizon Posts Triple-Digit Sales Growth After Adding Tepezza To Lineup
finance.yahoo.com - February 24 at 2:47 PM
Horizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 GuidanceHorizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 Guidance
finance.yahoo.com - February 24 at 9:47 AM
Horizons Breakthrough Year Ends With Fourth-Quarter Earnings BeatHorizon's 'Breakthrough Year' Ends With Fourth-Quarter Earnings Beat
finance.yahoo.com - February 24 at 9:47 AM
New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic PhaseNew Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
finance.yahoo.com - February 22 at 9:37 AM
Horizon Therapeutics (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseHorizon Therapeutics (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
msn.com - February 19 at 7:49 PM
Inovio Pharmaceuticals Shows Market Leadership With Jump To 86 RS RatingInovio Pharmaceuticals Shows Market Leadership With Jump To 86 RS Rating
finance.yahoo.com - February 18 at 1:21 PM
Horizon Pharma Shows Rising Price Performance With Jump To 85 RS RatingHorizon Pharma Shows Rising Price Performance With Jump To 85 RS Rating
finance.yahoo.com - February 3 at 4:31 PM
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021
finance.yahoo.com - February 3 at 11:31 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Viela Bio, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Viela Bio, Inc.
finance.yahoo.com - February 1 at 4:36 PM
This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.